Headquartered in Murray Hill, New Jersey, US, C.R. Bard (Bard) designs and manufactures medical, surgical, diagnostic and patient care devices. The company sells its products to hospitals, individual healthcare professionals, extended care health facilities and alternate site facilities in the US and in more than 100 other countries, principally in Europe and Japan. In general, Bard's products are intended to be used once and then discarded or implanted either temporarily or permanently.Bard serves the healthcare industry through five divisions ' Bard Access Systems Inc, Bard Electrophysiology Division, Bard Medical Division, Bard Peripheral Vascular Inc (including Bard Biopsy Systems) and Davol Inc ' and four major product group categories ' vascular, urology, oncology and surgical specialties. The company also has a product group of 'Other Products'.Vascular ' Bard offers a range of products for peripheral vascular indications, with a focus on vascular patency (keeping veins and arteries open), through its Bard Electrophysiology and Bard Peripheral Vascular division. Bard led the industry with the first angioplasty balloon catheter in 1980, giving cardiologists a safer and less costly alternative to open-heart procedures. Bard Peripheral Vascular, a leader in ePTFE vascular prosthetic technology, provides a portfolio of endovascular products, including the VenaFlo vascular graft and DistaFlo bypass grafts which offer an alternative to vein cuffs and patches when adequate autologous saphenous vein is not available.The January 2008 acquisition of the LifeStent family of stents from Edwards Lifesciences provided Bard with one of the broadest product offerings for peripheral vascular stentiUrology ' Bard claims to be the worldwide market leader in urological diagnostic and interventional products with a focus on urological drainage, continence and prostate disease management.The company believes its Foley Catheter, which it introduced over 70 years ago, remains one of the most important products in the urological field. One example of Bard's breakthroughs is the Bardex I.C. Foley Catheter with Bard hydrogel and Bacti-Guard silver alloy coating, which is clinically proven to substantially reduce the rate of urinary tract infections and reduce the cost of additional therapy and hospital days. Other products include the Contigen Bard Collagen Implant used to treat stress urinary incontinence and the Criticore Patient Monitor, an electronic monitoring device that measures a patient's core body temperature and fluid (urine or ultrafiltrate) output.Bard also entered the brachytherapy business in March 1998 with the purchase of Proseed Inc, which offers a turnkey programme that allows a hospital to implement brachytherapy treatment with lower investment cost and financial risk.Oncology ' Bard's oncology products and services are provided through Bard Access Systems, Bard Biopsy Systems and Bard Medical Division. They are designed for the detection, treatment and management of various cancers. These include specialty access catheters and ports; gastro-enterological products (endoscopic accessories, percutaneous feeding devices and stents); and biopsy devices.The acquisition of Dymax Corp extended Bard Access Systems' portfolio to include ultrasound systems that allow physicians to have real-time visualisation of needle placementSurgical Specialties ' Bard maintains a complete line of advanced surgical specialty products and services to complement its focus on disease state management. These products are produced by Bard Medical, Bard Peripheral Vascular and Davol and include prosthetics for soft tissue repair and irrigation products for orthopaedic and laparoscopic procedures and topical haemostatic devices.Other Products ' The other product group includes irrigation, wound drainage and certain original equipment manufacturers' products.Bard employs approximately 11,000 people. In 2008, the company generated revenues of US$2.45 billion,

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Bard Medical Device Company Intelligence Report
Published on September 2009
Report Summary
Headquartered in Murray Hill, New Jersey, US, C.R. Bard (Bard) designs and manufactures medical, surgical, diagnostic and patient
care devices. The company sells its products to hospitals, individual healthcare professionals, extended care health facilities and
alternate site facilities in the US and in more than 100 other countries, principally in Europe and Japan. In general, Bard's products
are intended to be used once and then discarded or implanted either temporarily or permanently.
Bard serves the healthcare industry through five divisions ' Bard Access Systems Inc, Bard Electrophysiology Division, Bard Medical
Division, Bard Peripheral Vascular Inc (including Bard Biopsy Systems) and Davol Inc ' and four major product group categories '
vascular, urology, oncology and surgical specialties. The company also has a product group of 'Other Products'.
Vascular ' Bard offers a range of products for peripheral vascular indications, with a focus on vascular patency (keeping veins and
arteries open), through its Bard Electrophysiology and Bard Peripheral Vascular division.
Bard led the industry with the first angioplasty balloon catheter in 1980, giving cardiologists a safer and less costly alternative to
open-heart procedures.
Bard Peripheral Vascular, a leader in ePTFE vascular prosthetic technology, provides a portfolio of endovascular products, including
the VenaFlo vascular graft and DistaFlo bypass grafts which offer an alternative to vein cuffs and patches when adequate autologous
saphenous vein is not available.
The January 2008 acquisition of the LifeStent family of stents from Edwards Lifesciences provided Bard with one of the broadest
product offerings for peripheral vascular stenti
Urology ' Bard claims to be the worldwide market leader in urological diagnostic and interventional products with a focus on urological
drainage, continence and prostate disease management.
The company believes its Foley Catheter, which it introduced over 70 years ago, remains one of the most important products in the
urological field. One example of Bard's breakthroughs is the Bardex I.C. Foley Catheter with Bard hydrogel and Bacti-Guard silver
alloy coating, which is clinically proven to substantially reduce the rate of urinary tract infections and reduce the cost of additional
therapy and hospital days. Other products include the Contigen Bard Collagen Implant used to treat stress urinary incontinence and
the Criticore Patient Monitor, an electronic monitoring device that measures a patient's core body temperature and fluid (urine or
ultrafiltrate) output.
Bard also entered the brachytherapy business in March 1998 with the purchase of Proseed Inc, which offers a turnkey programme
that allows a hospital to implement brachytherapy treatment with lower investment cost and financial risk.
Oncology ' Bard's oncology products and services are provided through Bard Access Systems, Bard Biopsy Systems and Bard
Medical Division. They are designed for the detection, treatment and management of various cancers. These include specialty access
Bard Medical Device Company Intelligence Report Page 1/9

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
catheters and ports; gastro-enterological products (endoscopic accessories, percutaneous feeding devices and stents); and biopsy
devices.
The acquisition of Dymax Corp extended Bard Access Systems' portfolio to include ultrasound systems that allow physicians to have
real-time visualisation of needle placement
Surgical Specialties ' Bard maintains a complete line of advanced surgical specialty products and services to complement its focus on
disease state management. These products are produced by Bard Medical, Bard Peripheral Vascular and Davol and include
prosthetics for soft tissue repair and irrigation products for orthopaedic and laparoscopic procedures and topical haemostatic devices.
Other Products ' The other product group includes irrigation, wound drainage and certain original equipment manufacturers' products.
Bard employs approximately 11,000 people. In 2008, the company generated revenues of US$2.45 billion, which made it the 28th
largest global medical device company. Bard's main competitors are Baxter International, Boston Scientific and Ethicon.
Table of Content
EXECUTIVE SUMMARY
OVERVIEW
Recent Key Events
Financial Results
Fiscal 2007
Table 1: Revenue by Operating Segment, 2005-2007 (US$ million)
Figure 1: Revenue by Operating Segment, 2002-2007 (US$ millions)
Table 2: Percentage of Revenue by Operating Segment, 2005-2007
Latest Results
First Quarter of Fiscal 2008
Table 3: Revenue by Product Group, First Quarter of Fiscal 2008 (US$ million)
Vascular Products
Urology Products
Oncology Products
Surgical Specialty Products
Table 4: Fiscal 2008 Guidance
STRATEGIC FOCUS
PRODUCT OVERVIEW
Urology Products
Vascular Products
Oncology Products
Bard Medical Device Company Intelligence Report Page 2/9

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Surgical Specialties
Figure 2: Percentage of Revenue by Product Area, 2007
Table 5: New Product Approvals
VASCULAR
Figure 3: Vascular Net Sales, 2002-2007 (US$ million)
Table 6: Vascular Segment - Key Products and 2007 Net Sales Growth
Endovascular Market
Peripheral Vascular Disease
Table 7: Market Rankings for Peripheral Products*
Figure 4: US PVD Market 2007 (US$1,070 million)*
PTA Market
Featured PTA Products
Conquest and Atlas
Dorado PTA Balloon Dilatation Catheter
New Competing PTA Products
AngioScore - AngioSculpt
Cordis ' Sleek and Savvy
Peripheral Stents
LifeStent
LifeStent RESILIENT Trial
E-Luminexx
Peripheral Stent Graft Market
Fluency
Fluency Plus
Flair
Vena Cava Filter Market
Bard's Vena Cava Filter Products
G2 and G2 Express
Competitors
Biopsy Market
Vacora
UltraClip
Competing Vacuum-Assisted Biopsy Systems
Core Needle Systems
Bard Magnum Reusable Biopsy System
Bard Max-Core Disposable Biopsy System
Electrophysiology Market
EP Competitive Landscape ' Treatment of Atrial Fibrillation
Bard HD Mesh Ablation System for treating AF
HD Mesh System ' US Clinical Trial
Figure 5: AF Market by Product Type, 2007*
Other Key Bard EP Products
LabSystem PRO
ElectroView 3D Mapping Software
Competing EP Products
UROLOGY AND CONTINENCE CARE
Figure 6: Bard's Urology Net Sales, 2002-2007 (US$ million)
Table 8: Urology Segment ' Bard's Key Products and 2007 Net Sales Growth
Urology Market Estimates and Competitors
Bard Medical Device Company Intelligence Report Page 3/9

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 9: Bard's and Coloplast's Urology Revenue, 2007
Bard's Key Urology Products
Infection Control Foley Catheters
Bardex I.C. Foley Catheter
Agento IC Infection Control Endotracheal Tube
StatLock Catheter Stabilisation Device
Continence Market
Stress Urinary Continence Market
Figure 7: Global SUI Market Shares*
Bard's SUI Products
Align Urethral Support System
Biological Tissue Urethral Support Systems
Urethral Bulking Products
Prolapse Market
Bard's Prolapse Products
Avaulta Plus
Competing Prolapse Products
ONCOLOGY
Oncology Market
Figure 8: Bard Oncology ' Ongoing Net Sales* 2003-2007 (US$ million)
Table 10: Total Reported Oncology Net Sales and Growth Rates
Oncology Segment - Key Products
Featured Bard Oncology Products
PICCs and Midlines
PowerPICC SOLO
Sherlock II Tip Locator System
Competing PICCs
Central Venous Catheters
PowerLine Central Venous Catheters
PowerHickman Catheters
CR Bard
Groshong Catheters
Site-Rite 6 Ultrasound System
Next-Generation Imaging Systems
PowerPorts
PowerPort isp M.R.I. device
PowerLoc Safety Infusion Set
Drainage
Aspira Pleural Drainage System
Competing Pleural Drainage Products
SURGICAL SPECIALTY PRODUCTS
Figure 9: Surgical Specialties Net Sales, 2002-2007 (US$ million)
Table 11: Surgical Specialties Segment - Key Products and 2007 Net Sales Growth
Hernia Repair Market
Bard's Hernia Repair and Hernia Fixation Portfolio
Bard's New Hernia Repair and Fixation Products
Sepramesh
Salute II Hernia Fixation System
Bard Medical Device Company Intelligence Report Page 4/9

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
PermaSorb
Market Estimates
Competitive Landscape
Table 12: Principal Hernia Repair Products competing with Bard
Figure 10: Worldwide Hernia Repair Market, 2007 *
RESEARCH AND DEVELOPMENT
Research Projects
Vascular Projects
Urology Projects
Surgical Projects
Endoscopic Suturing Device
RESTORE Study
Research Agreements
TyRx Pharma
INTERNATIONAL ACTIVITIES
Table 13: Net Sales by Geographic Location of Customer, 2005-2007 (US$ million)
Table 14: Percentage of Net Sales by Geographic Location of Customer, 2005-2007 (US$ million)
Table 15: Long-lived Assets by Geographic Location, 2005-2007 (US$ million)
Major International Manufacturing Locations
LATIN AMERICA
Puerto Rico.
Mexico
ASIA/PACIFIC
Malaysia
Japan.
APPENDICES
APPENDIX 1 - FINANCIAL INDICATORS
APPENDIX 2 - KEY CORPORATE EVENTS
APPENDIX 3 - MERGERS AND ACQUISITIONS
Specialized Health Products International
Specialized Health Products - Financial Results for Fiscal 2007
LifeStent Product Line from Edwards Lifesciences.
Inrad
Venetec International
CR Bard
PST's Self-Expanding Stent Assets
Genyx Medical
Sorenson Medical's Closed Suction Catheter System
Onux Medical
Bridger Biomedical
Prostate Services of America, Amertek Medical and Alton Design
Biomedical Instruments and Products GmbH's Biopsy Device
Source Tech Medical
Imagyn Medical Technologies - Rights to Seed Business
NMT Medical's Vena Cava Filter Business
Mill-Rose Laboratories
Bard Medical Device Company Intelligence Report Page 5/9

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Surgical Sense
Biosearch Medical Products' Intermittent Urinary Catheter Business
Dymax
ProSeed
Endomatrix
Impra
American Hydro-Surgical Instruments
Vas Cath
Angiomed
Cardial
Bainbridge Sciences
APPENDIX 4 - JOINT VENTURES
Medicon
APPENDIX 5 - MINORITY INVESTMENTS
Hydromer
Navarre Biomedical
APPENDIX 6 - DIVESTITURES
Endoscopic Technologies Business
Intra-Aortic Balloon Catheter and Pump Business
Coronary Cath Lab Business
Neonatal Product Line
Surgical Suction Product Line
Sani-Spec Product Line
Sure-Closure System
Inspiron Division
MedSystems Division
Shield Healthcare Centers
Electromedical Systems
APPENDIX 7 - AGREEMENTS
Genzyme
Tutogen Medical
Enpath Medical
CardioTech International
Mentor
Tissue Science Laboratories
Mediwatch
Floreane Medical Implants
Specialized Health Products International
Endologix
CR Bard
Collagen
Maelor
Integra LifeSciences
SUPPLY AGREEMENTS
Novation
Premier
NHS Purchasing and Supply Agency (UK)
APPENDIX 8 - LITIGATION
Department of Health and Human Services
Composix Claims
Bard Medical Device Company Intelligence Report Page 6/9

7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Southeast Missouri Hospital et al
W.L. Gore & Associates
Index of Ta bles
Table 1: Revenue by Operating Segment, 2005-2007 (US$ million)
Table 2: Percentage of Revenue by Operating Segment, 2005-2007
Table 3: Revenue by Product Group, First Quarter of Fiscal 2008 (US$ million)
Table 4: Fiscal 2008 Guidance
Table 5: New Product Approvals
Table 6: Vascular Segment - Key Products and 2007 Net Sales Growth
Table 7: Market Rankings for Peripheral Products*
Table 8: Urology Segment ' Bard's Key Products and 2007 Net Sales Growth
Table 9: Bard's and Coloplast's Urology Revenue, 2007
Table 10: Total Reported Oncology Net Sales and Growth Rates
Table 11: Surgical Specialties Segment - Key Products and 2007 Net Sales Growth
Table 12: Principal Hernia Repair Products competing with Bard
Table 13: Net Sales by Geographic Location of Customer, 2005-2007 (US$ million)
Table 14: Percentage of Net Sales by Geographic Location of Customer, 2005-2007 (US$ million)
Table 15: Long-lived Assets by Geographic Location, 2005-2007 (US$ million)
Index of Charts
Figure 1: Revenue by Operating Segment, 2002-2007 (US$ millions)
Figure 2: Percentage of Revenue by Product Area, 2007
Figure 3: Vascular Net Sales, 2002-2007 (US$ million)
Figure 4: US PVD Market 2007 (US$1,070 million)*
Figure 5: AF Market by Product Type, 2007*
Figure 6: Bard's Urology Net Sales, 2002-2007 (US$ million)
Figure 7: Global SUI Market Shares*
Figure 8: Bard Oncology ' Ongoing Net Sales* 2003-2007 (US$ million)
Figure 9: Surgical Specialties Net Sales, 2002-2007 (US$ million)
Figure 10: Worldwide Hernia Repair Market, 2007 *
Bard Medical Device Company Intelligence Report Page 7/9

8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Bard Medical Device Company Intelligence Report
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 462.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Bard Medical Device Company Intelligence Report Page 8/9

9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Bard Medical Device Company Intelligence Report Page 9/9